Banciu, Manuela <br/><br/>
Liposomal glucocorticoids as tumor-targeted anti-angiogenic nanomedicine in B16 melanoma-bearing mice.  [electronic resource] 

 -  The Journal of steroid biochemistry and molecular biology  Jul 2008 
 - 101-10 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0960-0760 
<br/><br/><label>Standard No.: </label>10.1016/j.jsbmb.2008.05.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Budesonide--administration & dosage<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Cells, Cultured<br/>Colonic Neoplasms--drug therapy<br/>Dexamethasone--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Drug Delivery Systems<br/>Endothelium, Vascular--drug effects<br/>Glucocorticoids--administration & dosage<br/>Inflammation--drug therapy<br/>Injections, Subcutaneous<br/>Liposomes<br/>Male<br/>Melanoma, Experimental--blood supply<br/>Methylprednisolone--administration & dosage<br/>Mice<br/>Mice, Inbred C57BL<br/>Nanomedicine<br/>Neovascularization, Pathologic--prevention & control<br/>Prednisolone--administration & dosage<br/>Receptors, Glucocorticoid--metabolism<br/>Time Factors<br/>Tumor Burden<br/>Umbilical Veins--cytology